- Home
- OGI vs SCPH Comparison
OGI vs SCPH Comparison
Compare OGI & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGI
- SCPH
- Stock Information
- Founded
- OGI 2013
- SCPH 2013
- Country
- OGI Canada
- SCPH United States
- Employees
- OGI N/A
- SCPH N/A
- Industry
- OGI Biotechnology: Pharmaceutical Preparations
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- OGI Health Care
- SCPH Health Care
- Exchange
- OGI Nasdaq
- SCPH Nasdaq
- Market Cap
- OGI 176.1M
- SCPH 274.7M
- IPO Year
- OGI N/A
- SCPH 2017
- Fundamental
- Price
- OGI $1.80
- SCPH $5.18
- Analyst Decision
- OGI
- SCPH Strong Buy
- Analyst Count
- OGI 0
- SCPH 1
- Target Price
- OGI N/A
- SCPH $18.00
- AVG Volume (30 Days)
- OGI 388.2K
- SCPH 255.8K
- Earning Date
- OGI 08-13-2024
- SCPH 11-06-2024
- Dividend Yield
- OGI N/A
- SCPH N/A
- EPS Growth
- OGI N/A
- SCPH N/A
- EPS
- OGI N/A
- SCPH N/A
- Revenue
- OGI $110,297,722.00
- SCPH $24,048,000.00
- Revenue This Year
- OGI $8.76
- SCPH $195.62
- Revenue Next Year
- OGI $14.04
- SCPH $145.07
- P/E Ratio
- OGI N/A
- SCPH N/A
- Revenue Growth
- OGI 2.33
- SCPH 549.77
- 52 Week Low
- OGI $0.97
- SCPH $3.24
- 52 Week High
- OGI $2.91
- SCPH $7.29
- Technical
- Relative Strength Index (RSI)
- OGI 47.72
- SCPH 51.38
- Support Level
- OGI $1.76
- SCPH $4.97
- Resistance Level
- OGI $2.00
- SCPH $5.63
- Average True Range (ATR)
- OGI 0.09
- SCPH 0.25
- MACD
- OGI -0.01
- SCPH -0.01
- Stochastic Oscillator
- OGI 28.57
- SCPH 38.96
About OGI Organigram Holdings Inc.
OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.